Skip to main content
Caplight Logo









PreTT ApS

PreTT ApS

Private
CopenhagenHealthcare & Life Scienceshttps://pre-tt.com/

Last Round

Grant

Feb 24, 2026

Total Funding Raised

$5.11M

Company Overview

PreTT ApS is a biotechnology company that develops pretargeted radioligand therapy platforms to improve the precision and effectiveness of cancer treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radioligand therapyRLTpretargeted therapyradioimmunotherapyprecision oncologytargeted cancer therapymonoclonal antibodiesradiotheranosticsdrug delivery technologyglioblastoma treatmentbiotech R&Dtheranosticstargeted alpha therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PreTT ApS Comparables

Compare PreTT ApS with similar companies based on industry and business-model similarity.

PreTT ApS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoOne
86%
Akiram Therapeutics
81%
Tagworks Pharmaceuticals
77%

PreTT ApS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 24, 2026
GrantApr 3, 2025
AcceleratorFeb 29, 2024

Key People

Founding team and executive leadership

MSc Natalia Herrero Alvarez

Chief Executive Officer, Director of R&D

Executive Team

PreTT ApS Investors

Notable investors and investment history

PreTT ApS investors
InvestorRounds
Innovation Fund DenmarkGrant
Eurostars SME programmeGrant
BioInnovation InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 29, 2024

    $541K raised from BioInnovation Institute

PreTT ApS Filings

Explore SEC and related filing metadata, where available.

PreTT ApS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PreTT ApS's valuation, stock price, and market status.

Is PreTT ApS a public or private company?

PreTT ApS is a private company.

What is the current stock price of PreTT ApS?

PreTT ApS is a private company with no public stock price. No recent secondary market data is available.

How much is PreTT ApS worth (valuation)?

Valuation information for PreTT ApS is not publicly available.

Can I buy PreTT ApS stock?

PreTT ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PreTT ApS's last funding round?

PreTT ApS's most recent funding round was Grant on February 24, 2026.

Who are the main investors in PreTT ApS?

Key investors in PreTT ApS include Innovation Fund Denmark, Eurostars SME programme, BioInnovation Institute.

Will PreTT ApS IPO soon?

No public IPO plans have been announced for PreTT ApS.

How can I track PreTT ApS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PreTT ApS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range4
Year Founded2022
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?